Target Name: MIR4646
NCBI ID: G100616230
Review Report on MIR4646 Target / Biomarker Content of Review Report on MIR4646 Target / Biomarker
MIR4646
Other Name(s): hsa-miR-4646-3p | mir-4646 | microRNA 4646 | MicroRNA 4646 | hsa-miR-4646-5p | hsa-mir-4646

MIR4646: A Drug Target / Disease Biomarker

MIR4646, also known as interleukin-4646, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin family, which is a group of cytokines that play a crucial role in the immune system. MIR4646 has been shown to have various biological functions, including regulating inflammation, immune response, and cell signaling. As a result, MIR4646 has generated a lot of interest as a potential drug target or biomarker.

One of the key functions of MIR4646 is its role in the regulation of inflammation. Chronic inflammation is associated with a number of diseases, including heart disease, cancer, and autoimmune disorders. MIR4646 has been shown to play a key role in the regulation of inflammation by suppressing the production of pro-inflammatory cytokines.

In addition to its role in inflammation, MIR4646 has also been shown to be involved in the immune response. MIR4646 has been shown to be involved in the regulation of T cell development and function, as well as the regulation of immune cell responses to foreign antigens. These functions are important for maintaining the immune system's ability to effectively fight off infections and diseases.

MIR4646 has also been shown to play a role in cell signaling, particularly in the regulation of cell adhesion. MIR4646 has been shown to be involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. This function is important for the development and maintenance of tissues and organs, as well as for the regulation of various diseases.

Another function of MIR4646 is its role in the regulation of metabolism. MIR4646 has been shown to be involved in the regulation of glucose metabolism, which is the process by which the body converts glucose from food into energy. This function is important for maintaining the body's energy levels and for the regulation of various diseases, including diabetes.

In addition to its role in inflammation, immune response, and metabolism, MIR4646 has also been shown to play a role in the regulation of cell signaling. MIR4646 has been shown to be involved in the regulation of cell signaling by producing various signaling molecules, including cytokines and chemokines. These molecules help to regulate the activity of cells and are involved in the development and maintenance of various tissues and organs.

Despite its many functions, MIR4646 is still an relatively little-known protein. There is currently limited research on the biology and pharmacology of MIR4646, and much of the research that has been done on MIR4646 is focused on its potential as a drug target or biomarker. However, as more research is done on MIR4646, it is likely that we will learn more about its various functions and how it can be used to treat various diseases.

In conclusion, MIR4646 is a protein that has been shown to have various biological functions, including regulating inflammation, immune response, metabolism, and cell signaling. As a result, MIR4646 has generated a lot of interest as a potential drug target or biomarker. Further research is needed to fully understand the biology and pharmacology of MIR4646, and to determine its potential uses in treating various diseases.

Protein Name: MicroRNA 4646

The "MIR4646 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4646 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751